The emerging field of retinal electrophysiological measurements in psychiatric research: A review of the findings and the perspectives in major depressive disorder

Journal of Psychiatric Research

Volumn 70, Issue , 2015, Pages 113-120

  Schwitzer, Thomas ^a,b,c   Lavoie, Joëlle ^d   Giersch, Anne ^c   Schwan, Raymund ^a,b   Laprevote, Vincent ^a,b,e  

^a UNIVERSITÉ DE LORRAINE   (France)

^b Institut lorrain de formation des cadres de santé ILFCS   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Biological marker; Electrooculogram; Electroretinogram; Major depressive disorder; Monoamine neurotransmission; Pathophysiology

Indexed keywords

DULOXETINE; MONOAMINE;

B WAVE; DISEASE SEVERITY; ELECTROOCULOGRAM; ELECTROPHYSIOLOGY; ELECTRORETINOGRAPHY; FLASH ELECTRORETINOGRAM; FOURIER ANALYSIS; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR DEPRESSION; MEDICAL RESEARCH; PATHOPHYSIOLOGY; PATTERN ELECTRORETINOGRAM; PRIORITY JOURNAL; REMISSION; RETINA CONE; RETINA ROD; REVIEW; TREATMENT DURATION; ELECTROOCULOGRAPHY; PROCEDURES; RETINA;

DEPRESSIVE DISORDER, MAJOR; ELECTROOCULOGRAPHY; HUMANS; RETINA;

EID: 84943403084     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.09.003     Document Type: Review

References (62)

1. aan het Rot M., Mathew S.J., Charney D.S. Neurobiological mechanisms in major depressive disorder. CMAJ Can. Med. Assoc. J. 2009 Feb 3, 180(3):305-313.
2. Arango V., Huang Y., Underwood M.D., Mann J.J. Genetics of the serotonergic system in suicidal behavior. J. Psychiatr. Res. 2003 Oct, 37(5):375-386.
3. Arden G.B., Constable P.A. The electro-oculogram. Prog. Retinal Eye Res. 2006 Mar, 25(2):207-248.
4. Bach M., Brigell M.G., Hawlina M., Holder G.E., Johnson M.A., McCulloch D.L., et al. ISCEV standard for clinical pattern electroretinography (PERG): 2012 update. Doc. Ophthalmol. Adv. Ophthalmol. 2013 Feb, 126(1):1-7.
5. Balogh Z., Benedek G., Kéri S. Retinal dysfunctions in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008 Jan 1, 32(1):297-300.
6. Belmaker R.H., Agam G. Major depressive disorder. N. Engl. J. Med. 2008 Jan 3, 358(1):55-68.
7. Berton O., Nestler E.J. New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 2006 Feb, 7(2):137-151.
8. Betz H., Laube B. Glycine receptors: recent insights into their structural organization and functional diversity. J. Neurochem. 2006 Jun, 97(6):1600-1610.
9. Bodis-Wollner I., Marx M.S., Mitra S., Bobak P., Mylin L., Yahr M. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain J. Neurol. 1987 Dec, 110(Pt 6):1675-1698.
10. Bubl E., Kern E., Ebert D., Bach M., Tebartz van Elst L. Seeing gray when feeling blue? Depression can be measured in the eye of the diseased. Biol. Psychiatry 2010 Jul 15, 68(2):205-208.
11. Bubl E., Ebert D., Kern E., van Elst L.T., Bach M. Effect of antidepressive therapy on retinal contrast processing in depressive disorder. Br. J. Psychiatry J. Ment. Sci. 2012 Aug, 201:151-158.
12. Bubl E., Kern E., Ebert D., Riedel A., Tebartz van Elst L., Bach M. Retinal dysfunction of contrast processing in major depression also apparent in cortical activity. Eur. Arch. Psychiatry Clin. Neurosci. 2015 Jun, 265(4):343-350.
13. Charney D.S., Manji H.K. Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci. STKE Signal Transduct. Knowl. Environ. 2004 Mar 23, 225:re5.
14. Djamgoz M.B., Hankins M.W., Hirano J., Archer S.N. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vis. Res. 1997 Dec, 37(24):3509-3529.
15. Economou S.G., Stefanis C.N. Electrooculographic (EOG) findings in manic-depressive illness. Acta Psychiatr. Scand. 1979 Aug, 60(2):155-162.
16. Emrich H.M., Ullrich A., Adamczyk J., Stein R. Lithium affects EOG in humans. Psychiatry Res. 1984 Dec, 13(4):355-357.
17. Fam J., Rush A.J., Haaland B., Barbier S., Luu C. Visual contrast sensitivity in major depressive disorder. J. Psychosom. Res. 2013 Jul, 75(1):83-86.
18. Fava M. Diagnosis and definition of treatment-resistant depression. Biol. Psychiatry 2003 Apr 15, 53(8):649-659.
19. Fava M., Davidson K.G. Definition and epidemiology of treatment-resistant depression. Psychiatr. Clin. North Am. 1996 Jun, 19(2):179-200.
20. Fornaro M., Bandini F., Ogliastro C., Cordano C., Martino M., Cestari L., et al. Electroretinographic assessment in major depressed patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background?. J. Affect. Disord. 2011 Dec, 135(1-3):154-159.
21. Fountoulakis K.N., Fotiou F., Iacovides A., Kaprinis G. Is there a dysfunction in the visual system of depressed patients?. Ann. Gen. Psychiatry 2005 Mar 29, 4(1):7.
22. Fountoulakis K.N., Gonda X., Andreoulakis E., Fokas K., Iacovides A. No differences between drug naive and drug experienced unipolar depressed patients in terms of neurobiological testing: a cross sectional study. J. Psychiatr. Res. 2013 Dec, 47(12):1984-1990.
23. Fountoulakis K.N., Iacovides A., Fotiou F., Nimatoudis J., Bascialla F., Ioannidou C., et al. Neurobiological and psychological correlates of suicidal attempts and thoughts of death in patients with major depression. Neuropsychobiology 2004, 49(1):42-52.
24. Friedman R.A. Antidepressants' black-box warning-10 years later. N. Engl. J. Med. 2014 Oct 30, 371(18):1666-1668.
25. Garcia-Martin E., Rodriguez-Mena D., Satue M., Almarcegui C., Dolz I., Alarcia R., et al. Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity. Invest. Ophthalmol. Vis. Sci. 2014 Feb, 55(2):696-705.
26. Gastinger M.J., Tian N., Horvath T., Marshak D.W. Retinopetal axons in mammals: emphasis on histamine and serotonin. Curr. Eye Res. 2006 Aug, 31(7-8):655-667.
27. Hamon M., Blier P. Monoamine neurocircuitry in depression and strategies for new treatments. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013 Aug 1, 45:54-63.
28. Hébert M., Beattie C.W., Tam E.M., Yatham L.N., Lam R.W. Electroretinography in patients with winter seasonal affective disorder. Psychiatry Res. 2004 Jun, 127(1-2):27-34.
29. Hébert M., Dumont M., Lachapelle P. Electrophysiological evidence suggesting a seasonal modulation of retinal sensitivity in subsyndromal winter depression. J. Affect. Disord. 2002 Apr, 68(2-3):191-202.
30. Holder G.E. Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog. Retinal Eye Res. 2001 Jul, 20(4):531-561.
31. Holder G.E., Celesia G.G., Miyake Y., Tobimatsu S., Weleber R.G. International federation of clinical neurophysiology. International federation of clinical neurophysiology: recommendations for visual system testing. Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol. 2010 Sep, 121(9):1393-1409.
32. Hood D.C., Bach M., Brigell M., Keating D., Kondo M., Lyons J.S., et al. ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc. Ophthalmol. Adv. Ophthalmol. 2012 Feb, 124(1):1-13.
33. Hoon M., Okawa H., Della Santina L., Wong R.O.L. Functional architecture of the retina: development and disease. Prog. Retinal Eye Res. 2014 Sep, 42C:44-84.
34. Kessler R.C., Bromet E.J. The epidemiology of depression across cultures. Annu. Rev. Public Health 2013, 34:119-138.
35. Lam R.W., Beattie C.W., Buchanan A., Remick R.A., Zis A.P. Low electrooculographic ratios in patients with seasonal affective disorder. Am. J. Psychiatry 1991 Nov, 148(11):1526-1529.
36. Langheinrich T., Tebartz van Elst L., Lagrèze W.A., Bach M., Lücking C.H., Greenlee M.W. Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol. 2000 Jan, 111(1):66-74.
37. Laprevote V., Schwitzer T., Giersch A., Schwan R. Flash electroretinogram and addictive disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2015 Jan 2, 56:264.
38. Lavoie J., Hébert M., Beaulieu J.-M. Looking beyond the role of glycogen synthase kinase-3 genetic expression on electroretinogram response: what about lithium?. Biol. Psychiatry 2015 Feb 1, 77(3):e15-e17.
39. Lavoie J., Illiano P., Sotnikova T.D., Gainetdinov R.R., Beaulieu J.-M., Hébert M. The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders. Biol. Psychiatry 2014 Mar 15, 75(6):479-486.
40. Lavoie J., Maziade M., Hébert M. The brain through the retina: the flash electroretinogram as a tool to investigate psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014 Jan 3, 48:129-134.
41. Lavoie M.-P., Lam R.W., Bouchard G., Sasseville A., Charron M.-C., Gagné A.-M., et al. Evidence of a biological effect of light therapy on the retina of patients with seasonal affective disorder. Biol. Psychiatry 2009 Aug 1, 66(3):253-258.
42. Luo X., Frishman L.J. Retinal pathway origins of the pattern electroretinogram (PERG). Invest. Ophthalmol. Vis. Sci. 2011, 52(12):8571-8584.
43. Marmor M.F., Brigell M.G., McCulloch D.L., Westall C.A., Bach M. International society for clinical electrophysiology of vision. ISCEV standard for clinical electro-oculography (2010 update). Doc. Ophthalmol. Adv. Ophthalmol. 2011 Feb, 122(1):1-7.
44. McCulloch D.L., Marmor M.F., Brigell M.G., Hamilton R., Holder G.E., Tzekov R., et al. ISCEV standard for full-field clinical electroretinography (2015 update). Doc. Ophthalmol. Adv. Ophthalmol. 2015 Feb, 130(1):1-12.
45. Osborne N.N. Noradrenaline, a transmitter candidate in the retina. J. Neurochem. 1981 Jan, 36(1):17-27.
46. Ozaki N., Rosenthal N.E., Moul D.E., Schwartz P.J., Oren D.A. Effects of phototherapy on electrooculographic ratio in winter seasonal affective disorder. Psychiatry Res. 1993 Nov, 49(2):99-107.
47. Peppe A., Stanzione P., Pierantozzi M., Semprini R., Bassi A., Santilli A.M., et al. Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss?. Electroencephalogr. Clin. Neurophysiol. 1998 Apr, 106(4):374-382.
48. Porciatti V., Alesci R., Bagnoli P., Signorini G., Raffaelli A. Serotonin depletion modifies the pigeon electroretinogram. Doc. Ophthalmol. Adv. Ophthalmol. 1989 May, 72(1):93-100.
49. Reis R.A.M., Ventura A.L.M., Kubrusly R.C.C., de Mello M.C.F., de Mello F.G. Dopaminergic signaling in the developing retina. Brain Res. Rev. 2007 Apr, 54(1):181-188.
50. Rey G., Knoblauch K., Prévost M., Komano O., Jouvent R., Dubal S. Visual modulation of pleasure in subjects with physical and social anhedonia. Psychiatry Res. 2010 Apr 30, 176(2-3):155-160.
51. Rosenthal N.E., Sack D.A., Gillin J.C., Lewy A.J., Goodwin F.K., Davenport Y., et al. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch. Gen. Psychiatry 1984 Jan, 41(1):72-80.
52. Rudolf G., Wioland N. Effects of intravitreal and intravenous administrations of dopamine on the standing potential and the light peak in the intact chicken eye. Curr. Eye Res. 1990 Nov, 9(11):1077-1082.
53. Schneider T., Zrenner E. Effects of D-1 and D-2 dopamine antagonists on ERG and optic nerve response of the cat. Exp. Eye Res. 1991 Apr, 52(4):425-430.
54. Schwitzer T., Schwan R., Angioi-Duprez K., Ingster-Moati I., Lalanne L., Giersch A., et al. The cannabinoid system and visual processing: a review on experimental findings and clinical presumptions. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 2015 Jan, 25(1):100-112.
55. Seggie J., MacMillan H., Griffith L., Shannon H.S., Martin J., Simpson J., et al. Retinal pigment epithelium response and the use of the EOG and Arden ratio in depression. Psychiatry Res. 1991 Feb, 36(2):175-185.
56. Smith K. Mental health: a world of depression. Nature 2014 Nov 13, 515(7526):181.
57. de Souza C.F., Acosta M.L., Polkinghorne P.J., McGhee C.N.J., Kalloniatis M. Amino acid immunoreactivity in normal human retina and after brachytherapy. Clin. Exp. Optom. J. Aust. Optom. Assoc. 2013 Sep, 96(5):504-507.
58. Tebartz van Elst L., Greenlee M.W., Foley J.M., Lücking C.H. Contrast detection, discrimination and adaptation in patients with Parkinson's disease and multiple system atrophy. Brain J. Neurol. 1997 Dec, 120(Pt 12):2219-2228.
59. Thase M.E. Molecules that mediate mood. N. Engl. J. Med. 2007 Dec 6, 357(23):2400-2402.
60. Wimmers S., Karl M.O., Strauss O. Ion channels in the RPE. Prog. Retinal Eye Res. 2007 May, 26(3):263-301.
61. Witkovsky P. Dopamine and retinal function. Doc. Ophthalmol. Adv. Ophthalmol. 2004 Jan, 108(1):17-40.
62. Wu S.M., Maple B.R. Amino acid neurotransmitters in the retina: a functional overview. Vis. Res. 1998 May, 38(10):1371-1384.